Improving Healthcare and Skincare Profitability by Reducing Inefficient Advertising Expenses
First written in FY2018-Q3. 3 of 7 entries say "Advanced", first in FY2018. Latest entry: FY2021-Q1.
The whole theme swung hardest in 2019: 2 of 19 companies on the "Worse" side.
0 other companies' latest entry also says "Dropped".
- FY2021-Q1DroppedAnnual report
「As all shares of Kyusai Co., Ltd. had been transferred during the cumulative period of the first quarter, the company and its subsidiaries have been excluded from the Group.」
The company subject to the healthcare and skincare business’s advertising expense reduction and profitability improvement measures was excluded from consolidation. - FY2020-Q3AdvancedAnnual report
「In the healthcare and skincare business, business profit was ¥2,622 million, up ¥132 million, or 5.3%, year on year, due to efforts to reduce costs and deploy promotional spending effectively.」
Although revenue declined due to COVID-19 and other factors, cumulative business profit through the third quarter increased 5.3% year on year due to cost reductions and the effective use of promotional spending. - FY2020-Q2AdvancedAnnual report
「In the healthcare and skincare business, business profit was ¥1,829 million, up ¥229 million, or 14.3%, year on year, due to efforts to reduce costs and deploy promotional spending effectively.」
The company continued to reduce costs and use promotional spending effectively, and first-half business profit in the healthcare and skincare business increased 14.3% year on year. - FY2019-Q2RestatedAnnual report
「In the healthcare and skincare business, business profit was ¥1,600 million, down ¥1,239 million, or 43.7%, year on year, as declining revenue outweighed reductions in expenses achieved through the effective use of promotional costs and other measures.」
Expenses continued to decline through the effective use of promotional costs and other measures, but business profit fell 43.7% year on year due to declining revenue. - FY2019-Q1Profit declined despite continued expense controlsAnnual report
「In the healthcare and skincare business, business profit was ¥714 million, down ¥838 million, or 54.0%, year on year, due to declining revenue despite progress in controlling expenses such as promotional costs.」
Expenses such as promotional costs continued to be controlled, but business profit fell 54.0% year on year due to declining revenue. - FY2018AdvancedAnnual report
「In the healthcare and skincare business, business profit was ¥5,337 million, up ¥297 million, or 6%, from the previous fiscal year, mainly due to reductions in inefficient advertising expenses and other factors.」
The company reduced inefficient advertising expenses, and business profit in the healthcare and skincare business increased 6% year on year. - FY2018-Q3First statedAnnual report
「In the healthcare and skincare business, operating profit was ¥2,567 million, up ¥302 million, or 13%, year on year, mainly due to reductions in inefficient advertising expenses and other factors.」
The filing states that reducing inefficient advertising expenses increased operating profit in the healthcare and skincare business by 13% year on year.